BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11673541)

  • 1. Hepatitis C virus core protein inhibits human T lymphocyte responses by a complement-dependent regulatory pathway.
    Yao ZQ; Nguyen DT; Hiotellis AI; Hahn YS
    J Immunol; 2001 Nov; 167(9):5264-72. PubMed ID: 11673541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation.
    Kittlesen DJ; Chianese-Bullock KA; Yao ZQ; Braciale TJ; Hahn YS
    J Clin Invest; 2000 Nov; 106(10):1239-49. PubMed ID: 11086025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt.
    Yao ZQ; Eisen-Vandervelde A; Waggoner SN; Cale EM; Hahn YS
    J Virol; 2004 Jun; 78(12):6409-19. PubMed ID: 15163734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus: immunosuppression by complement regulatory pathway.
    Yao ZQ; Ray S; Eisen-Vandervelde A; Waggoner S; Hahn YS
    Viral Immunol; 2001; 14(4):277-95. PubMed ID: 11792059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV core/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27Kip1.
    Yao ZQ; Eisen-Vandervelde A; Ray S; Hahn YS
    Virology; 2003 Sep; 314(1):271-82. PubMed ID: 14517080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein.
    Giambartolomei S; Covone F; Levrero M; Balsano C
    Oncogene; 2001 May; 20(20):2606-10. PubMed ID: 11420671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. gC1qR expression in chimpanzees with resolved and chronic infection: potential role of HCV core/gC1qR-mediated T cell suppression in the outcome of HCV infection.
    Yao ZQ; Shata MT; Tricoche N; Shan MM; Brotman B; Pfahler W; Hahn YS; Prince AM
    Virology; 2006 Mar; 346(2):324-37. PubMed ID: 16368125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
    Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
    J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early immune response and regulation of IL-2 receptor subunits.
    Hughes-Fulford M; Sugano E; Schopper T; Li CF; Boonyaratanakornkit JB; Cogoli A
    Cell Signal; 2005 Sep; 17(9):1111-24. PubMed ID: 15993752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway.
    Yu TK; Caudell EG; Smid C; Grimm EA
    J Immunol; 2000 Jun; 164(12):6244-51. PubMed ID: 10843677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential activation of T cell cytokine production by the extracellular signal-regulated kinase (ERK) signaling pathway.
    Egerton M; Fitzpatrick DR; Catling AD; Kelso A
    Eur J Immunol; 1996 Oct; 26(10):2279-85. PubMed ID: 8898934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of SOCS-1 signalling in B and T lymphocytes by hepatitis C virus core protein.
    Yao ZQ; Prayther D; Trabue C; Dong ZP; Moorman J
    Immunology; 2008 Oct; 125(2):197-207. PubMed ID: 18397267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection.
    Zhang Y; Ma CJ; Ni L; Zhang CL; Wu XY; Kumaraguru U; Li CF; Moorman JP; Yao ZQ
    J Immunol; 2011 Mar; 186(5):3093-103. PubMed ID: 21263070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production.
    Waggoner SN; Hall CH; Hahn YS
    J Leukoc Biol; 2007 Dec; 82(6):1407-19. PubMed ID: 17881511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell dysfunction by hepatitis C virus core protein involves PD-1/PDL-1 signaling.
    Yao ZQ; King E; Prayther D; Yin D; Moorman J
    Viral Immunol; 2007; 20(2):276-87. PubMed ID: 17603844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of p38- and gC1qR-dependent IL-8 expression in pulmonary fibroblasts by soluble hepatitis C core protein.
    Moorman JP; Fitzgerald SM; Prayther DC; Lee SA; Chi DS; Krishnaswamy G
    Respir Res; 2005 Sep; 6(1):105. PubMed ID: 16164755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus core protein reduces CD8
    Khan ST; Karges W; Cooper CL; Crawley AM
    Immunology; 2018 May; 154(1):156-165. PubMed ID: 29266204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction.
    Tao X; Davis LS; Hashimoto K; Lipsky PE
    J Pharmacol Exp Ther; 1996 Jan; 276(1):316-25. PubMed ID: 8558449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of gC1qR+CD4+ T cells increases during acute hepatitis C virus infection and remains elevated in patients with chronic infection.
    Cummings KL; Rosen HR; Hahn YS
    Clin Immunol; 2009 Sep; 132(3):401-11. PubMed ID: 19473882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus core protein induces an anergic state characterized by decreased interleukin-2 production and perturbation of mitogen-activated protein kinase responses.
    Sundström S; Ota S; Dimberg LY; Masucci MG; Bergqvist A
    J Virol; 2005 Feb; 79(4):2230-9. PubMed ID: 15681425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.